A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata.
Saved in:
| Title: | A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata. |
|---|---|
| Authors: | Anderson S; Department of Hearing and Speech Sciences, University of Maryland, College Park, Maryland, USA., Cavaletti G; Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy., Hood LJ; Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Polydefkis M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Herrmann DN; Department of Neurology, University of Rochester, Rochester, New York, USA., Rance G; Department of Audiology and Speech Pathology, The University of Melbourne, Carlton, Victoria, Australia., King B; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA., McMichael AJ; Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Senna MM; Department of Dermatology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Kim BS; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Napatalung L; Pfizer Inc, New York, New York, USA.; Mount Sinai Hospital, New York, New York, USA., Wolk R; Pfizer Inc, Groton, Connecticut, USA., Zwillich SH; Pfizer Inc, Groton, Connecticut, USA., Schaefer G; Pfizer Pharma GmbH, Berlin, Germany., Gong Y; Pfizer Inc, New York, New York, USA., Sisson M; Pfizer Inc, Groton, Connecticut, USA., Posner HB; Pfizer Inc, New York, New York, USA. |
| Source: | Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Aug; Vol. 12 (4), pp. e1204. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
